Prot #20200439: A Phase 1b Study Evaluating the Safety and Efficacy of AMG 757 in Combination with AMG 404 in Subjects with Small Cell Lung Cancer (SCLC)

Project: Research project

Project Details

StatusActive
Effective start/end date3/2/223/2/25

Funding

  • Amgen, Inc. ((OE) Prot #20200439)